Pioneering Composite Programmable Therapeutics
At CPTx, we develop new treatment paradigms across unmet medical challenges, with an initial focus on infectious diseases.
The flexibility and precision of CPTx's platform support multivalent drug development, which is crucial for addressing complex disease states involving multiple binding sites, such as viruses, cancer, and autoimmune diseases.
Programmable Medicines
We are developing a new generation of programmable therapeutics that demonstrate significant advantages over traditional monovalent drug approaches.
Our platform facilitates the precise placement and polyvalent presentation of a variety of drug molecules, which is crucial for addressing complex disease states involving multiple binding sites, such as viruses, cancer, and autoimmune diseases.
